Who's the real invasive species: us or them? Ecologists are rethinking urban biodiversity
Climate change is already having a profound impact on cities, as global urbanization pushes more and more people to live in them. The animals who cohabitate with human, whether we appreciate their presence or not, are changing too. Specifically, there's been an increase in invasive species — a term used to describe introduced organisms that bring dramatic and often destructive changes, and sometimes can drive other species to extinction.
But here's the thing: Invasive species don't stop evolving themselves. Consider the infamous brown rats of New York City, which have evolved longer noses and shorter upper molar tooth rows, the better to enjoy the Big Apple's colder weather and higher-quality food. Other invasive species are adapting behaviorally, physically and genetically to life in cities as well. While invasive species pose major public health implications and can certainly affect humans' quality of life, their adaptive abilities can rival those of human migrants and pose a puzzling question: Who's the real invader here?
Brian Verrelli, a professor in the Center of Biological Data Science at Virginia Commonwealth University, sees many of these questions as philosophical.
"What does it mean to invade something, right?" he asked in a video interview. "What does it mean for humans to invade one area or another? Are there areas that we invade, or are humans welcome freely to move around the planet? We know that's the case in some places, and certainly not the case in others.
"It's a bit of an interesting, hypocritical conversation," Verrelli added, given that "we are facilitating the movement of these organisms around the planet."
Rats have invaded new continents because ships carrying them in the hold. Spiders move across continents inside our cars. And we have all literally "translocated" organisms from one place to another, Verrelli said, because we wanted to — flowers and household pets, for example.
"Traveling globally, one can notice the same suite of species in many cities around the world — biological invasions creating a kind of global Cuisinart where the urban biota becomes homogeneous," Laura Meyerson, a professor at the University of Rhode Island who studies invasive species and ecological restoration, told Salon. "
She cited the nearly ubiquitous tree of heaven (Ailanthus altissima), which is found in cities around the world. "This introduced tree is threatening important ancient ruins such as the Roman Colosseum. Interestingly, it is the host plant in its native range for the spotted lanternfly," an invasive pest that has recently gotten a lot of attention in North America. "Other common species in urban areas globally are Norway rats and English pigeons, both of which can spread disease," Meyerson said, along with "European starlings and the common reed (Phragmites australis), both of those being aggressive introduced species that displace native species."
But Verrelli believes that if we can't exactly determine who counts as an invader, we also can't really say what's being invaded. That might sound like an abstruse philosophical argument, but he says it's a hot debate within the scientific community.
"We have what are called 'stud books' for our primates at zoos all over the world," Verrelli said. "We don't count that as invasion, but we are directly facilitating that. I'm hitting this note because it very much underlies our idea of invasion and gene flow, how genetics moves around and what it means to point to an organism and say it belongs to a certain species."
Verrelli has studied the spread of black widow spiders, an increasing medical health concern in cities along the West Coast. People now encounter these potentially deadly spiders, which used to be found in isolated desert areas, in urban or suburban garages and yards. "As we're altering the landscape within cities, these areas are becoming attractive to black widows," Verrelli said. "They're all around us now, so we need to be able to understand what's happening as they're moving into cities."
There are important health and environmental questions about whether black widows are becoming more deadly or displacing other arachnid species, but Verrelli raises a different question: "They were here first. Are they really invading the urban area? Yes, because we plopped the urban area down in the middle of the desert." Verrelli spent nine years in Arizona, an arid environment where many organisms struggle to survive, but that has now been altered and made more hospitable by human habitation.
Indeed, the American Southwest is particularly vulnerable to invasive species, including highly adaptive species that can affect human health, largely thanks to the rapid spread of urbanism — which can bring water to desert environments while also creating artificial heat islands in colder climates, and allowing tropical species to expand their ranges.
Meyerson defines invasive species as "non-native species introduced either intentionally or accidentally by humans outside of their native range," while noting a crucial distinction between non-native but non-invasive species — tulips were imported to North America from Europe, for example, but do no ecological harm — and invasive ones.
Most invasion scientists aim "to prevent introductions of harmful invasive species in the first place through public education, better screening tools and risk assessments," she said. But once such species are introduced, detecting and eradicating them quickly becomes the goal. If that doesn't work, the next goal is about managing and containing them, preventing further spread, and supporting native species by managing green spaces and natural habitats within the urban environment. "Urban areas can also be important stopover sites for migrating species," she added. "We need to manage these areas to help support these seasonal migrations."
It's no longer reasonable, Verrelli believes, to draw a neat line between urban and wild spaces. "For a very long time, even most scientists studying urban areas as ecologists didn't really treat urban areas as 'natural' environments, because humans lived in them," he said. "That's something that I smile at, because if we don't believe humans are part of the natural world, we're in trouble. Most of our natural world is going to be consumed by humans, in which case we're ignoring a major influence on how organismal biodiversity is successful."
Patterns of evolution play out in urban environments. A classic example often taught in high school biology classes is that of industrial melanism in the peppered moth, a British species tha looks, well, "peppered," with black dots on a mostly white background. There had always been occasional all-black moths, but from the mid-19th century, observers began to see more and more black moths in the industrial cities of England and Scotland. The mostly white moths stood out in the sooty environment and became easy prey for predators. Ultimately, the ones able to blend in were more likely to survive and reproduce.
This is an adaptation — in evolutionary biology, a trait that arose due to natural selection. But when we casually talk about species adapting to life in the big city, that's not always what we're describing. A bear that overturns your trash can and figures out how to get your leftovers isn't "adapting"; it's just repurposing a behavior that evolved in its natural or ancestral environment. This kind of transfer of an evolutionary adaptation to a new context is called "exaptation."
"It's really important that we know the difference between these two," Verrelli said. "We're not just trying to classify for the purpose of classification. If we can tell the exaptations versus the adaptations, then we are going to really understand the selective agents." Verrelli cites the work of Kristen Winchell at NYU, who has studied anoles lizards moving from forests into urban areas in Puerto Rico. In cities, she found, these lizards evolved longer legs relative to their body size, allowing them to crawl up metal pipes. That's not an exaptation, where the same structures that let them climb trees are applied to the new setting, but actual evolutionary adaptations. In Verrelli's view, understanding this difference isn't about discouraging these animals' presence, but making it easier for us and them to live in harmony and reasonable comfort. If an urban lizard can't climb up a pipe, an urban cat may select it right out of existence.
"How do we design the urban environment to make them more readily livable to these organisms?" Verrelli asks. "What kind of surfaces should we be developing? What kind of areas? Where do we put light, where do we not put light?" Such questions will be "very important to understanding how organisms can move through urban environments."
Sometimes our attempts to address invasive species can be counterproductive: Meyerson cites the example of the American elm, a formerly popular street tree appreciated not only for their beauty but also their hardiness under harsh urban conditions. But Dutch elm disease, an invasive fungus spread by bark beetles to which the native trees had no defense, has decimated the elm by tens of millions across the continent. "Ironically, many of these street trees were replaced by other introduced invasive species such as Norway maple or callery pear," she said, "which in turn have their own impacts." Introduced species are wreaking havoc due to similar lack of evolved defenses in the American beech, many amphibian species and North American bats of different kinds. Generalist creatures, those that can thrive in a variety of environments, will most easily adapt to city life and may go on to decimate native species.
There is general agreement that we are no longer dealing with either a purely urban, human environment or a purely wild and untouched one.
But while Verrelli belongs to one side in the ongoing debate among conservation biologists, the other includes those who believe cities are an incurable blight and that their spread must be reduced or reversed. His side, roughly speaking, sees urbanization as a permanent reality and harmonious biodiversity — sharing these spaces with our plant and animal relatives — as the most important goal. They see the distinction between wild spaces and urban spaces collapsing, which is happening anyway, not always harmoniously.
"In understanding invasion, we need to learn more about cities," Verrelli said. "We need to learn more about invaders. We need to learn more about how they're doing, what they're doing. That's why we study things like bedbugs and black widows, because these are good models to learn about how this is happening, and because it's going to keep happening.
"Instead of the idea of, let's go study things outside of cities, because this are the important areas we need to conserve, I'm on the other side. We need to study invasions in cities, because this is largely the future, whether we like it or not. As we move into the future, we're preparing a new landscape that's evolving all the time. Let's prepare biodiversity for it as well."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Severed Feet In Canada, The Mystery Of "Titanic's" Skeletons, John Wayne Gacy's Last Meal, And A Bunch Of Other Creepy Stuff
Do you love all things weird, dark, and creepy? Subscribe to the That Got Dark newsletter to get a weekly post just like this delivered directly to your inbox. It's a scary good time you won't want to miss. Hello, friends! I'm Crystal, and I loooove going down a deep and dark rabbit hole, particularly late at night. And I wonder why I have trouble falling asleep…ha! But, much like going to a scary movie, I don't like doing it alone. So, every week, I'll gather the darkest, weirdest, and creepiest things I find on the internet (and beyond) to share just with you, my spooky-loving friends. So, tuck yourself in tight and get out that flashlight…it's about to get dark. Something that kept me up all night recently was the question: Where are the bones of the people who drowned when the Titanic sank? (Yes, these are the kinds of things I think about.) We always see STUFF in photos and videos of the wreck — parts of the ship, fancy dishes, personal belongings like watches and shoes — but we never see human remains, specifically bones. I decided to do a little deep-diving (no pun intended) and found a very simple but absolutely nightmarish answer. In an old NPR interview, deep-sea explorer Robert Ballard explained that the ship's wreck rests below the calcium carbonate compensation depth. What this means is that far down in the ocean, calcium carbonate (which is a primary component of bones) dissolves faster than it can accumulate. So, basically, after sinking to the bottom of the ocean floor, the victims' flesh was eaten by sea creatures, and then their bones DISSOLVED. Have fun thinking about that tonight. Related: If You Get 12/15 On This Honors Vocab Quiz, Your IQ Has To Be At Least 150 Occasionally, I like to ask the BuzzFeed Community to tell me about the most mysterious, cult-like, bad-vibes towns in the United States they've ever been to. And you'd be shocked at how many responses I get each time (or maybe not). This week's spotlight: Vidor, Texas 'It's just east of Beaumont and still a sundown town. Local infrastructure vendors, i.e. Telco, power, etc., know to send only white workers to that town for safety. I've been through once, and it just feels off, but I was also traveling with a Black friend." —Ok-disaster2022 Interesting fact: The 2017 film Three Billboards Outside Ebbing, Missouri was inspired by the murder of Kathy Page in Vidor, Texas, and the billboards her father, James Fulton, put up after demanding justice. Wikipedia is like the Wild West. It's vast, lawless, and sometimes you can find some extremely weird things out there, like: the Salish Sea human foot discoveries Since August of 2007, there have been at least 20 DETACHED human feet discovered off the coasts of British Columbia in Canada and Washington state in the US. There are a ton of theories as to why JUST feet have been found — ranging from boating accidents, plane crashes, suicide, foul play, and even the 2004 Indian Ocean tsunami — but no one really knows the truth and they probably never will. Related: This Prom Dress Generator Will Help You Design Your Actual Dream Dress, And I'm Sort Of Obsessed With It Anton Yelchin — Died: June 19, 2016, Cause of Death: Crushed by his Jeep Grand Cherokee How he died: The promising young actor who starred in films like Odd Thomas and the popular Star Trek reboots was killed when his 2015 Cherokee rolled backward down the driveway of his Los Angeles home and then pinned him between the mailbox and security fence. His official cause of death was listed as 'blunt traumatic asphyxia.' Yelchin's parents eventually filed a lawsuit against Fiat Chrysler (the makers of the Jeep Grand Cherokee), as his vehicle was among 1.1 million others recalled. They reached a confidential settlement in 2018. Strange Darling (2024) What it's about: Nothing is what it seems when a twisted one-night stand spirals into a serial killer's vicious murder spree. Why you should watch it: This acclaimed indie horror has a 96% rating on Rotten Tomatoes and Master of Horror himself, Stephen King, called it 'a clever masterpiece.' Where you can watch it: Streaming for free on Paramount+ or for rent for $2.99 on Fandango at Home. John Wayne Gacy Known as the 'Killer Clown' — a moniker given because of his public appearances as a clown before the discovery of his crimes — John Wayne Gacy was a serial killer active in the Chicago area in the 1970s, who had at least 33 victims. He would rape and torture his victims — young men and boys — before killing them either by asphyxiation or strangulation. Gacy was executed by lethal injection in May 1994. His last meal: A bucket of KFC chicken, 12 fried prawns, a pound of strawberries, French fries, and a Diet Coke. Well, we survived another week, friend. In the next issue, I'll talk about a teenage TikToker who recklessly killed six people, a medieval torture device I can't believe was actually real, and Ted Bundy's last meal. Until then, stay safe, keep the lights on, and I'll see you for another horrifying trip down the rabbit hole… Got a weird, creepy, or shocking story you want to share? Tell me all about it at thatgotdark@ and, who knows, maybe it'll be featured in a future post or issue of That Got Dark! Want more? Subscribe to the That Got Dark newsletter to get a weekly post just like this delivered directly to your inbox. It's a scary good time you won't want to miss. Also in BuzzFeed: 37 School Scandals That Are So Wild, They Should Be Optioned For A Documentary Also in BuzzFeed: These Visual Riddles Are Perhaps The Easiest Thing In The World To Solve — Can You Figure Them Out? Also in BuzzFeed: Only "Former Gifted Kids" Will Know What These 24 Words Mean

Associated Press
an hour ago
- Associated Press
Adolore BioTherapeutics Announces Publication Demonstrating Biosafety and Efficacy of Kv7 Activating rdHSV-CA8* Analgesic Gene Therapy for Chronic Pain via the Intra-Articular Route in Mice
Findings highlight the advantages of Adolore's approach for the delivery of proprietary gene therapy directly to specialized pain-sensing peripheral nerves (nociceptors) that mediates profound analgesia with the potential to address the great unmet need for non-opioid chronic pain therapies Data further supports the clinical-translational value of Adolore's proprietary non-opioid analgesics for treating chronic non-cancer pain These data support the Company's continuing efforts to progress with IND-enabling studies of ADB-102 gene therapy for the treatment of osteoarthritis (OA) chronic knee pain. DELRAY BEACH, FL / ACCESS Newswire / June 15, 2025 / Adolore BioTherapeutics ('Adolore' or the 'Company'), a biotechnology company focused on developing breakthrough opioid-free gene therapy treatments for chronic pain and neurological disorders, today announced the publication of its manuscript titled, 'Biosafety and Efficacy of Kv7 Activating rdHSV-CA8* Analgesic Gene Therapy for Chronic Pain Via the Intra-Articular Route in Mice1,' in the peer-reviewed journal, Molecular Therapy. Roy Clifford Levitt, MD, Clinical Professor at the University of Miami, Principal Investigator and Program Director of the NIH, NINDS, HEAL Award supporting ADB-102 development for the treatment of chronic knee pain due to OA, and Founder & Executive Chairman of Adolore BioTherapeutics, published biosafety and efficacy data from preclinical studies of Adolore's gene therapy expressing a human carbonic anhydrase-8 variant peptide (CA8*). In model systems, replication-defective, disease-free, herpes simplex virus (rdHSV) gene therapy expressing an analgesic carbonic anhydrase-8 (CA8*) peptide variant corrects somatosensory hyperexcitability by activating Kv7 voltage-gated potassium channels, produces profound, long-lasting analgesia and treats chronic pain from knee OA. In these studies, we provide the first non-Good Laboratory Practices (GLP) biosafety, efficacy, biodistribution, shedding, and histopathology examination of this rdHSV-CA8* via the intra-articular knee route of administration. Naive mice were examined for clinical safety, distribution of virus across all major tissues, knee histopathology, and analgesic efficacy. We observed no signs of persistent toxicity or histopathology, viral genomes remained where they were injected, and there was no evidence of shedding. Profound analgesia persisted for >6 months without functional impairments. These initial biosafety and efficacy data support further development of rdHSV-CA8* for treating chronic knee pain due to moderate-to-severe OA. Dr. Levitt, commented, 'Kv7 voltage-gated potassium channel activators, like rdHSV-CA8* open these channels and hyperpolarize nociceptors making them less excitable to produce profound analgesia. Kv7 activators are well-known to produce potent non-opioid-based analgesia in many human chronic pain conditions. While Kv7 openers are no longer available due to off-target adverse events related to systemic administration, they have been successfully translated from animal models to human chronic pain conditions. Bolstered by our substantial body of published data, we continue to develop our innovative approach to address the significant serious unmet need for safe and effective locally acting pain therapies to replace opioids. Our preclinical data strongly support continued preclinical development toward an IND and clinical studies of ADB-102.' The Company's lead development program for the treatment of chronic pain in knee osteoarthritis is fully funded by a UG3/UH3 grant awarded to the University of Miami by NIH/NINDS HEAL program to support all formal pre-clinical GLP/GMP/GCP development work through a first-in-human study of ADLR-1l01 in patients expected to commence in 2026. 1 Levitt et al., Biosafety and efficacy of Kv7 activating rdHSV-CA8* analgesic gene therapy for chronic pain via the intraarticular route in mice, Molecular Therapy (2025), About Carbonic Anhydrase-8 (CA8*) Gene Therapy CA8* (variants of naturally occurring human carbonic anhydrase-8 analgesic peptides) gene therapies are a novel class of neuronal calcium channel inhibitors that activate Kv7 voltage-gated potassium channels and are administered locally and long-acting. Oral small molecule pain therapeutics that activate Kv7 voltage-gated potassium channels demonstrated proven analgesic efficacy before they were removed from the market due to severe adverse events related to systemic exposure and their metabolism. CA8* gene therapy provides versatile dosing regimens and routes of administration, including intra-articular, intra-neuronal (nerve block), and intradermal injection. This non-opioid CA8* mechanism-of-action addresses neuropathic, inflammatory, and nociceptive pain, which applies to a broad range of chronic pain indications and neurological disorders. These conditions include osteoarthritis, lower back, and cancer pain; diabetes and other forms of peripheral neuropathy; as well as rare pain conditions such as erythromelalgia, a heritable chronic pain condition and epilepsy and hearing loss. About Adolore BioTherapeutics, Inc. Adolore BioTherapeutics, Inc., is a biotechnology company focused on developing novel therapies for treating chronic pain using a revolutionary intra-cellular replication-defective HSV (rdHSV) drug delivery platform that is disease-free, non-toxic, and permits localized peripheral nervous system delivery of proprietary biotherapeutics. This rdHSV gene therapy technology incorporates an established re-dosing strategy and an excellent safety profile. HSV vectors are known for their stability and prolonged gene expression, providing an excellent basis for the long- term treatment of chronic pain conditions and neurological disorders. Our best-in-class CA8* programs are long-acting, locally administered gene therapies that are opioid-free Disease-Modifying Anti-Pain therapies (DMAPs) designed to treat many forms of chronic pain, epilepsy and hearing loss. Leveraging its innovative gene therapy vectors expressing CA8* analgesic peptides (ADLR-1001), Adolore is currently advancing two preclinical development programs: ADB-101 for the treatment of patients' chronic pain caused by erythromelalgia, an orphan disease, and ADB-102, their lead program for the treatment of patients with chronic pain caused by knee OA. Based on substantial compelling preclinical data generated to date, the Company is progressing these programs toward IND filings and first-in-human clinical studies. Adolore has two additional programs: ADB-104 for Drug-Resistant Refractory Focal Epilepsy and ADB-105 for Acute Severe Hearing Loss. For more information, visit Forward-Looking Statements To the extent, this announcement contains information and statements that are not historical, they are considered forward-looking statements within the meaning of the federal securities laws. You can identify forward-looking statements by the use of the words 'believe,' 'expect,' 'anticipate,' 'intend,' 'estimate,' 'project,' 'will,' 'should,' 'may,' 'plan,' 'intend,' 'assume' and other expressions which predict or indicate future events and trends and which do not relate to historical matters. You should not rely on forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, some of which are beyond the control of the Company. These risks and uncertainties include but are not limited to those associated with drug development. These risks, uncertainties, and other factors may cause the actual results, performance, or achievements of the Company to be materially different from the anticipated future results, performance, or achievements expressed or implied by the forward- looking statements. Investor Relations Contact Paul Barone (215)622-4542 [email protected] SOURCE: Adolore Biotherapeutics, Inc. press release


Digital Trends
an hour ago
- Digital Trends
SpaceX's Starlink rival is about to launch more internet satellites — here's how to watch
Amazon is preparing to launch its second batch of Project Kuiper internet satellites to orbit as it seeks to build out a constellation to take on SpaceX's Starlink service. The KA-02 mission had been delayed due to inclement weather, but Amazon and rocket provider United Launch Alliance (ULA) appear confident that it can send the satellites skyward on Monday, June 16. An Atlas V 551 rocket, configured with five side-mounted solid rocket boosters and a medium-length payload fairing, will launch the Project Kuiper satellites from Cape Canaveral in Florida. Amazon launched its first batch of 27 Project Kuiper satellites a couple of months ago, and Monday's mission will also carry the same number. The company is hoping to launch a global high-speed, low-latency satellite-powered internet service with as few as 1,000 satellites by the end of this year. Building out the constellation to the targeted 3,200 satellites will help to boost network performance and reliability for paying customers. SpaceX's Starlink initiative began deploying internet satellites in 2019 and so has a major head start on Amazon, but over time, Project Kuiper hopes to differentiate itself by offering affordable user terminals as well as exploiting Amazon Web Services for advanced cloud integration. By focusing on seamless connectivity for remote and underserved regions, and integrating with existing telecom infrastructure, Project Kuiper is seeking to carve out a significant share in the rapidly growing internet satellite sector, though clearly it's going to take several years to before it has any chance of reaching its goal. How to watch Amazon and ULA are targeting 1:25 p.m. ET (10:25 a.m. PT) on Monday, June 16, for the launch the KA-02 mission from Cape Canaveral in Florida. You can watch a livestream of the launch via the player embedded at the top of this page. The broadcast will begin at about 1 p.m. ET (10 a.m. PT). Additionally, if you live on the East Coast and the skies are clear, there's a chance you'll be able to see the rocket heading to orbit. This chart reveals how many seconds after launch it will take for the rocket to become visible, depending on your location.